Indivior Pharmaceuticals, Inc. Common Stock – Chart, Kurs & Nachrichten (NASDAQ:INDV)

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Market Capitalization 4.1234 B
Employee 838
Founded 2014
CEO Mark Crossley
Website www.indivior.com
Headquarter Delaware, United States
FIGI BBG01ZTXFLQ6
Industry Technology

Gesamtumsatz

Jahresüberschuss

Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

4.12 B Marktkapitalisierung

Kurs-Gewinn-Verhältnis

21.88

Preis-Umsatz-Verhältnis

3.71

Indivior Pharmaceuticals Inc

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

INDV

Financials

Indivior Pharmaceuticals Inc

Nachrichten

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

ASML, An AI Megatrend Star, Leads 8 Newcomers To Best Stock Lists

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus